CorMedix reports strong Q3 earnings, raises 2025 revenue guidance
PositiveFinancial Markets

CorMedix has reported impressive earnings for the third quarter, showcasing strong financial performance that has led the company to raise its revenue guidance for 2025. This positive news reflects the company's growth trajectory and confidence in its future prospects, which is significant for investors and stakeholders looking for promising opportunities in the healthcare sector.
— Curated by the World Pulse Now AI Editorial System











